Psychedelic Space
Psychedelic Experience October 26, 2023 DOI: 10.1093/oso/9780198843757.003.0003 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Key points | Proposes that psychedelic experiences vary along four dimensions—scope, clarity, novelty, and duration—forming a 'psychedelic space' that allows experiences to be simultaneously mind-revealing and mind-distorting. |
Abstract
Abstract This chapter provides a novel explication of the concept of psychedelic experience, understood as a mind-revealing experience. After reviewing the history of the concept of psychedelic experience, the chapter argues that experiences can be psychedelic in varying degrees and in different ways. In particular, the chapter argues that experiences can be more or less psychedelic by varying with respect to four dimensions: (i) scope, (ii) clarity, (iii) novelty, and (iv) duration. These four dimensions form the conceptual framework of psychedelic space, and they can be used to distinguish different ways that experiences may be more or less psychedelic. Special attention is paid to the dimension of clarity, as it allows us to differentiate between experiences that accurately reveal the mind and those that do not. This, in turn, allows for a more nuanced approach to psychedelic experiences, allowing them to be simultaneously mind-revealing in some respects and mind-distorting in others.
Citations in the library
Cites 243
- The benefits of being present: Mindfulness and its role in psychological well-being. Journal of Personality and Social Psychology 2003
- On a confusion about a function of consciousness Behavioral and Brain Sciences June 1, 1995
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Experience sampling during fMRI reveals default network and executive system contributions to mind wandering. Proceedings of the National Academy of Sciences May 26, 2009
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
and 238 more in the library